NASDAQ:MACK
Merrimack Pharmaceuticals Stock News
$15.00
-0.0300 (-0.200%)
At Close: May 03, 2024
Merrimack Reports First Quarter 2020 Financial Results
10:10pm, Thursday, 07'th May 2020
Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) today announced its first quarter 2020 financial results for the period ended March 31, 2020.
Merrimack Reports First Quarter 2020 Financial Results
12:00am, Thursday, 07'th May 2020
Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) today announced its first quarter 2020 financial results for the period ended March 31, 2020.
US Stock Market Weekly Update March 30- April 3, 2020
03:03pm, Sunday, 05'th Apr 2020
For the week ending on April 3, the US stock market declined and all major stock indexes had losses. We had a negative figure for the US non-far payrolls and the weekly US jobless claims, showing the
Merrimack Pharma Reports Receipt Of $2.25M Related To Closing Of Asset Sale For Preclinical Nanoliposome Programs To Celator Pharma
12:44pm, Thursday, 02'nd Apr 2020Merrimack Divests Early Stage Asset for $2.25 Million; Provides Strategy Update
12:30pm, Thursday, 02'nd Apr 2020
Merrimack Announces Sale Of Early Stage Asset for $2.25 Million And Provides Strategy Update.
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 23.) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * Be
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 23.)
Arcutis Biotherapeutics...
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) Biomerica, Inc. (NASDAQ: BMRA ) Centogene NV (NASD
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 19.)
Biomerica, Inc. (NASDAQ...
Stocks That Hit 52-Week Lows On Thursday
02:49pm, Thursday, 19'th Mar 2020
On Thursday morning, 1178 companies hit new 52-week lows.
Facts of Interest:
The largest company by market cap to set a new 52-week low was Nuveen Preferred & Income...
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
11:37am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) Biomerica, Inc. (NASDAQ: BMRA )( announced commen
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
12:00am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 18)
Biomerica, Inc. (NASDAQ...
The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates
07:36am, Wednesday, 18'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 17) …
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
11:37am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 11)
Bicycle Therapeutics...
